0
0

End Tuberculosis Now Act of 2024

10/8/2024, 12:59 PM

Summary of Bill S 288

Bill 118 s 288, also known as the End Tuberculosis Now Act of 2024, is a piece of legislation introduced in the US Congress with the goal of combating and ultimately eradicating tuberculosis (TB) in the United States. The bill aims to address the growing public health crisis posed by TB, which remains a significant threat despite advances in medical science.

The End Tuberculosis Now Act of 2024 proposes a comprehensive approach to tackling TB, including increased funding for research and development of new treatments, improved access to care for individuals affected by TB, and enhanced public health initiatives to prevent the spread of the disease. The bill also seeks to strengthen international partnerships and cooperation in the fight against TB, recognizing that the disease knows no borders and requires a global response.

Key provisions of the bill include the establishment of a national TB control program, increased funding for TB research and treatment programs, and the development of a national strategy to eliminate TB in the United States. The bill also calls for greater coordination between federal, state, and local health agencies in addressing TB, as well as increased education and awareness efforts to reduce stigma and discrimination associated with the disease. Overall, the End Tuberculosis Now Act of 2024 represents a significant step forward in the fight against TB in the United States, signaling a commitment to ending this preventable and treatable disease once and for all.

Congressional Summary of S 288

End Tuberculosis Now Act of 2023

This bill authorizes actions, including the provision of international assistance, to combat tuberculosis.

The President may provide international assistance to prevent, treat, control, and eliminate tuberculosis. The President must also establish goals for U.S. efforts to detect, cure, and prevent all forms of tuberculosis globally by updating the National Action Plan for Combating Multidrug-Resistant Tuberculosis.

The Government Accountability Office must periodically report to Congress on the impact of efforts to combat tuberculosis that are supported by U.S. bilateral assistance.

Current Status of Bill S 288

Bill S 288 is currently in the status of Passed in Senate since September 19, 2024. Bill S 288 was introduced during Congress 118 and was introduced to the Senate on February 7, 2023.  Bill S 288's most recent activity was Held at the desk. as of September 23, 2024

Bipartisan Support of Bill S 288

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
8
Democrat Cosponsors
4
Republican Cosponsors
4
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 288

Primary Policy Focus

International Affairs

Potential Impact Areas

- Cardiovascular and respiratory health
- Child health
- Congressional oversight
- Drug therapy
- Emergency medical services and trauma care
- Foreign aid and international relief
- Health care coverage and access
- Health personnel
- Health programs administration and funding
- Health promotion and preventive care
- Infectious and parasitic diseases
- International organizations and cooperation
- Medical education
- Medical research
- Medical tests and diagnostic methods
- Multilateral development programs
- Research and development
- World health

Alternate Title(s) of Bill S 288

End Tuberculosis Now Act of 2024
A bill to prevent, treat, and cure tuberculosis globally.
End Tuberculosis Now Act of 2024
End Tuberculosis Now Act of 2023

Comments

Gwen Monroe profile image

Gwen Monroe

451

1 year ago

I'm not sure about this new bill, but how will it impact us in the short term?